Remdesivir Global Market Report 2020-30: COVID 19 Growth and Change

Jul 2020| TBR1061A| TBRC (Publisher)

Sample Report

Report Highlights

Including:

1) By Route of Administration: Oral; Intravenous
2) By Dosage Form: Tablets; Frozen Solution; Lypholized Solution
3) By Distribution Channel: Hospitals; Clinics; Drug Stores/Pharmacies; Online; Others

Covering: Gilead Sciences, Inc.; Bright Gene; Hainan Haiyao; Kelun Pharma; Hunan Warrant Pharmaceutical

Remdesivir Global Market Report 2020-30: COVID 19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global remdesivir market.

This report focuses on remdesivir market which is experiencing strong growth. The report gives a guide to the remdesivir market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the remdesivir? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Remdesivir market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider remdesivir market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID 19 virus and forecasting its growth.
Market segmentations break down market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID 19 for all regions, key developed countries and major emerging markets.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
The remdesivir market section of the report gives context. It compares the remdesivir market with other segments of the remdesivir market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, remdesivir indicators comparison.

Scope

Markets Covered: 1) By Route of Administration: Oral; Intravenous
2) By Dosage Form: Tablets; Frozen Solution; Lypholized Solution
3) By Distribution Channel: Hospitals; Clinics; Drug Stores/Pharmacies; Online; Others

Companies Mentioned: Gilead Sciences, Inc.; Bright Gene; Hainan Haiyao; Kelun Pharma; Hunan Warrant Pharmaceutical

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table 1 : Global Historic Market Growth, 2015-2019, $ Billion
Table 2 : Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3 : Global Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 4 : Global Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 5 : Global Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 6 : Global Remdesivir Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 7 : Global Remdesivir Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 8 : Asia-Pacific, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 9 : Asia-Pacific, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 10 : China, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 11 : China, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 12 : India, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 13 : India, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 14 : Japan, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 15 : Japan, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 16 : Australia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 17 : Australia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 18 : Indonesia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 19 : Indonesia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 20 : South Korea, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 21 : South Korea, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 22 : Western Europe, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 23 : Western Europe, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 24 : UK, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 25 : UK, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 26 : Germany, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 27 : Germany, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 28 : France, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 29 : France, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 30 : Eastern Europe, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 31 : Eastern Europe, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 32 : Russia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 33 : Russia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 34 : North America, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 35 : North America, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 36 : USA, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 37 : USA, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 38 : South America, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 39 : South America, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 40 : Brazil, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 41 : Brazil, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 42 : Middle East, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 43 : Middle East, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 44 : Africa, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 45 : Africa, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 46 : Gilead Sciences, Inc. Financial Performance
Table 47 : Bright Gene Financial Performance
Table 48 : Hainan Haiyao Financial Performance
Table 49 : Kelun Pharma Financial Performance
Table 50 : Hunan Warrant Pharmaceutical Financial Performance

Figure 1 : Global Historic Market Growth, 2015-2019, $ Billion
Figure 2 : Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 3 : Global Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 4 : Global Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 5 : Global Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 6 : Global Remdesivir Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 7 : Global Remdesivir Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 8 : Asia-Pacific, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 9 : Asia-Pacific, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 10 : China, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 11 : China, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 12 : India, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 13 : India, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 14 : Japan, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 15 : Japan, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 16 : Australia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 17 : Australia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 18 : Indonesia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 19 : Indonesia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 20 : South Korea, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 21 : South Korea, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 22 : Western Europe, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 23 : Western Europe, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 24 : UK, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 25 : UK, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 26 : Germany, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 27 : Germany, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 28 : France, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 29 : France, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 30 : Eastern Europe, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 31 : Eastern Europe, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 32 : Russia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 33 : Russia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 34 : North America, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 35 : North America, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 36 : USA, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 37 : USA, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 38 : South America, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 39 : South America, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 40 : Brazil, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 41 : Brazil, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 42 : Middle East, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 43 : Middle East, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 44 : Africa, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 45 : Africa, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 46 : Gilead Sciences, Inc. Financial Performance
Figure 47 : Bright Gene Financial Performance
Figure 48 : Hainan Haiyao Financial Performance
Figure 49 : Kelun Pharma Financial Performance
Figure 50 : Hunan Warrant Pharmaceutical Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Remdesivir Global Market Report 2020-30: COVID 19 Growth and Change

Report Highlights

FAQ